Search research articles
Contact Us
Filters
Showing results (101-110 of 111) with videos related to
Page
of 12
Sort By:
British Journal of Cancer
|
July 12, 2019
Multi-omic molecular comparison of primary versus metastatic pancreatic tumours
Gagandeep Brar, Edik M Blais, R Joseph Bender, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 6, 2021
Targeting the NTRK Fusion Gene in Pancreatic Acinar Cell Carcinoma: A Case Report and Review of the Literature
Medhavi Gupta, Christopher Sherrow, Maghan E Krone, et al.
The Lancet. Oncology
|
March 6, 2020
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial
Michael J Pishvaian, Edik M Blais, Jonathan R Brody, et al.
JCO Precision Oncology
|
February 1, 2022
Outcomes in Patients With Pancreatic Adenocarcinoma With Genetic Mutations in DNA Damage Response Pathways: Results From the Know Your Tumor Program
Michael J Pishvaian, Edik M Blais, Jonathan R Brody, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2018
Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative
Michael J Pishvaian, Robert J Bender, David Halverson, et al.
Cancer Biology & Therapy
|
July 29, 2016
Identification of a novel metabolic-related mutation (IDH1) in metastatic pancreatic cancer
Jonathan R Brody, Cinthya S Yabar, Mahsa Zarei, et al.
American Journal of Clinical Pathology
|
April 20, 2024
Keratin 17 is a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma
Lyanne A Delgado-Coka, Lucia Roa-Peña, Sruthi Babu, et al.
Cancers
|
May 15, 2018
A New Strategy to Control and Eradicate "Undruggable" Oncogenic K-RAS-Driven Pancreatic Cancer: Molecular Insights and Core Principles Learned from Developmental and Evolutionary Biology
Robert E Van Sciver, Michael P Lee, Caroline Dasom Lee, et al.
Research Square
|
March 11, 2024
Keratin 17 modulates the immune topography of pancreatic cancer
Lyanne A Delgado-Coka, Michael Horowitz, Mariana Torrente-Goncalves, et al.
Journal of Translational Medicine
|
May 10, 2024
Keratin 17 modulates the immune topography of pancreatic cancer
Lyanne Delgado-Coka, Michael Horowitz, Mariana Torrente-Goncalves, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 111) with videos related to
Sort By:
Page
of 12
British Journal of Cancer
|
July 12, 2019
Multi-omic molecular comparison of primary versus metastatic pancreatic tumours
Gagandeep Brar, Edik M Blais, R Joseph Bender, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 6, 2021
Targeting the NTRK Fusion Gene in Pancreatic Acinar Cell Carcinoma: A Case Report and Review of the Literature
Medhavi Gupta, Christopher Sherrow, Maghan E Krone, et al.
The Lancet. Oncology
|
March 6, 2020
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial
Michael J Pishvaian, Edik M Blais, Jonathan R Brody, et al.
JCO Precision Oncology
|
February 1, 2022
Outcomes in Patients With Pancreatic Adenocarcinoma With Genetic Mutations in DNA Damage Response Pathways: Results From the Know Your Tumor Program
Michael J Pishvaian, Edik M Blais, Jonathan R Brody, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2018
Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative
Michael J Pishvaian, Robert J Bender, David Halverson, et al.
Cancer Biology & Therapy
|
July 29, 2016
Identification of a novel metabolic-related mutation (IDH1) in metastatic pancreatic cancer
Jonathan R Brody, Cinthya S Yabar, Mahsa Zarei, et al.
American Journal of Clinical Pathology
|
April 20, 2024
Keratin 17 is a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma
Lyanne A Delgado-Coka, Lucia Roa-Peña, Sruthi Babu, et al.
Cancers
|
May 15, 2018
A New Strategy to Control and Eradicate "Undruggable" Oncogenic K-RAS-Driven Pancreatic Cancer: Molecular Insights and Core Principles Learned from Developmental and Evolutionary Biology
Robert E Van Sciver, Michael P Lee, Caroline Dasom Lee, et al.
Research Square
|
March 11, 2024
Keratin 17 modulates the immune topography of pancreatic cancer
Lyanne A Delgado-Coka, Michael Horowitz, Mariana Torrente-Goncalves, et al.
Journal of Translational Medicine
|
May 10, 2024
Keratin 17 modulates the immune topography of pancreatic cancer
Lyanne Delgado-Coka, Michael Horowitz, Mariana Torrente-Goncalves, et al.
Page
of 12